MicroRNAs (miRNAs) are key post‐transcriptional regulators of gene expression with central roles in immune responses, inflammation, and viral pathogenesis. Increasing evidence indicates that severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) infection induces marked dysregulation of host and viral miRNAs (v‐miRNAs), contributing to disease severity during acute COVID‐19 and to the persistent manifestations observed in long COVID (LC). This narrative review critically synthesizes current evidence on miRNA dysregulation across the acute and post‐acute phases of COVID‐19, highlighting their pathogenic roles, clinical relevance, and existing knowledge gaps. During acute infection, altered miRNA profiles—including those associated with immune activation, endothelial dysfunction, and immunothrombosis—reflect both host responses and viral strategies of immune modulation, including miRNAs carried by extracellular vesicles (EVs) and SARS‐CoV‐2–derived v‐miRNAs. In LC, emerging data suggest that persistent miRNA alterations are associated with unresolved inflammation, pulmonary dysfunction, neurological symptoms, and vascular injury, although available studies remain limited and heterogeneous. Overall, miRNAs represent promising biomarkers and potential therapeutic targets in COVID‐19; however, robust longitudinal and mechanistic studies are urgently needed to clarify their causal roles and translational utility in post‐acute disease.
The Canine Transmissible Venereal Tumor (CTVT) is a unique neoplasm due to its ability to be transmitted between individuals of the same species, implant in a new host, and persist as clonal tumor cells. This study evaluates the use of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers and their relationship with therapeutic response and cytological characteristics of CTVT. Cytological and hematological samples from 22 dogs diagnosed with CTVT were analyzed, classifying cytological subtypes into lymphocyte-rich, plasmacytoid, and mixed. Tumor-derived NLR showed a significant correlation with cytological subtypes and tumor stage, being higher in progressive tumors and in the mixed and lymphocyte-rich subtypes. In contrast, systemic NLR did not show significant differences at the onset of treatment but gained relevance during specific therapy stages. Pre-chemotherapy PLR values were associated with treatment response, highlighting its utility as a dynamic indicator. These findings underscore the importance of NLR and PLR as accessible and cost-effective tools for characterizing the tumor microenvironment and evaluating therapeutic response in veterinary oncology, offering potential applications for comparative oncology in humans.
Background/Objective: Pulmonary fungal infections are a significant diagnostic challenge, primarily affecting immunocompromised individuals, such as those with HIV, cancer, or organ transplants, and they often lead to substantial morbidity and mortality if untreated. These infections trigger acute inflammatory and immune responses, which may progress to chronic inflammation. This process involves myofibroblast recruitment, the deposition of extracellular matrix, and vascular remodeling, ultimately contributing to pulmonary hypertension. Despite its clinical relevance, pulmonary hypertension secondary to fungal infections remains under-recognized in practice and poorly studied in research. Results/Conclusion: This narrative mini-review explores three key mechanisms underlying vascular remodeling in this context: (1) endothelial injury caused by fungal emboli or autoimmune reactions, (2) direct vascular remodeling during chronic infection driven by inflammation and fibrosis, and (3) distant vascular remodeling post-infection, as seen in granulomatous diseases like paracoccidioidomycosis. Further research and clinical screening for pulmonary hypertension in fungal infections are crucial to improving patient outcomes.